Marwell Bio Inc.
South San Francisco, CA
- UEI
- PTX1ZT26L8V3
- CAGE
- 967L9
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 470 Noor Ave #1011, South San Francisco, CA 94080, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $666,821 |
| FY2025 | $355,000 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Defense Advanced Research Projects Agency | $721,821 |
Contract awards
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase i: advanced deep learning technologies for designing humanized antibody | National Science Foundation | $294,822 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Integral Molecular Inc. | Philadelphia, PA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Celdara Medical, LLC | Lebanon, NH | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Traverse Biotech II Inc. | New York, NY | — |
| Parabon Nanolabs, Inc. | Reston, VA | 541713 Research and Development in Nanotechnology |
| Mapp Biopharmaceutical, Inc. | San Diego, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Marwell Bio Inc., a South San Francisco-based small disadvantaged woman-owned business, provides AI-driven antibody design and synthetic biology research services to federal agencies as a prime recipient and prime contractor, competing exclusively in innovation and research set-asides rather than full-and-open procurements. The company holds WOSB and self-certified small disadvantaged business designations and operates as a for-profit corporate entity.
Marwell's federal footprint spans three awards across three distinct agencies, totaling $1.7 million in combined potential value. The Defense Advanced Research Projects Agency awarded a $1.35 million Other Transaction Agreement on April 2, 2026, supporting the Biological Technologies Office's Network of Optimal Dynamic Energy Signatures (NODES) program for generalized embeddings with sequence-to-functions annotations for antibody design, with work performed in South San Francisco and completion scheduled for April 1, 2027. The National Cancer Institute awarded a $355 thousand Small Business Innovation Research Phase I contract on September 15, 2025, for next-generation dual targeting antibody-drug conjugates (ADCs) for small cell lung cancer empowered by generative AI, with completion due September 14, 2026. The National Science Foundation awarded a federal grant for SBIR Phase I research on advanced deep learning technologies for designing humanized antibodies, awarded September 1, 2023, with ultimate completion August 31, 2025 — work focused on developing AI-based computational models to accelerate therapeutic antibody design and reduce development timelines and costs.
All three awards function as prime work with no subcontract footprint. Customer concentration is diffuse across research and development agencies, with DARPA anchoring the largest single award at $1.35 million and NIH-NCI and NSF splitting the remainder. Two of the three awards (combined potential value $1.7 million) reach ultimate completion within the next twenty-four months, presenting full recompete exposure across the vendor's current active portfolio.
Quick answers
Is Marwell Bio Inc. registered in SAM.gov?
Yes. Marwell Bio Inc.'s SAM.gov registration is active through April 21, 2027.
How much has Marwell Bio Inc. received in federal contracts?
Federal contracts obligated $355,000 to Marwell Bio Inc. in fiscal year 2025 and $1,021,821 in fiscal years 2023 through 2027.
What is Marwell Bio Inc.'s most recent federal award?
Marwell Bio Inc.'s most recent federal contract award is Biological technologies office (BTO) - network of optimal dynamic energy signatures (nodes) - generalized embeddings… (HR0011269E075), from Defense Advanced Research Projects Agency, on April 2, 2026.
On GovTribe
See Marwell Bio Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors